Robin W.M. Vernooij
About
Robin W.M. Vernooij is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Robin W.M. Vernooij has authored 167 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 33 papers in Economics and Econometrics and 31 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robin W.M. Vernooij's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Clinical practice guidelines implementation (27 papers) and Dialysis and Renal Disease Management (22 papers). Robin W.M. Vernooij is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Clinical practice guidelines implementation (27 papers) and Dialysis and Renal Disease Management (22 papers). Robin W.M. Vernooij collaborates with scholars based in Netherlands, Spain and United Kingdom. Robin W.M. Vernooij's co-authors include Gabriel Martínez‐Rico, Pablo Alonso‐Coello, Gordon Guyatt, Xavier Bonfill, Anne WS Rutjes, Marcello Di Nisio, Laura Martínez García, Dena Zeraatkar, Bradley C. Johnston and Małgorzata M Bała and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
In The Last Decade
Robin W.M. Vernooij
153 papers receiving 3.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Robin W.M. Vernooij Netherlands | 33 | 1.1k | 562 | 562 | 453 | 433 | 167 | 3.9k | ||
| Idris Guessous Switzerland | 40 | 1.1k 1.0× | 407 0.7× | 661 1.2× | 989 2.2× | 212 0.5× | 306 | 5.9k | ||
| Michail Chourdakis Greece | 33 | 1.0k 0.9× | 438 0.8× | 1.2k 2.2× | 240 0.5× | 401 0.9× | 154 | 4.2k | ||
| Matthew J. Gurka United States | 43 | 1.1k 1.0× | 598 1.1× | 794 1.4× | 452 1.0× | 637 1.5× | 200 | 5.5k | ||
| Hsing‐Yi Chang Taiwan | 36 | 1.2k 1.1× | 416 0.7× | 993 1.8× | 220 0.5× | 354 0.8× | 168 | 4.9k | ||
| Stephanie N. Dixon Canada | 25 | 1.7k 1.6× | 640 1.1× | 1.1k 1.9× | 746 1.6× | 382 0.9× | 106 | 6.7k | ||
| Mark McEvoy Australia | 45 | 1.3k 1.2× | 790 1.4× | 1.3k 2.3× | 448 1.0× | 297 0.7× | 220 | 7.0k | ||
| Shih‐Han S. Huang Canada | 16 | 1.6k 1.4× | 424 0.8× | 1.1k 1.9× | 671 1.5× | 185 0.4× | 53 | 5.5k | ||
| Frank J.A. van Rooij Netherlands | 39 | 1.1k 1.0× | 547 1.0× | 1.1k 1.9× | 471 1.0× | 179 0.4× | 83 | 4.9k | ||
| Regina El Dib Brazil | 36 | 826 0.8× | 667 1.2× | 684 1.2× | 563 1.2× | 95 0.2× | 116 | 3.8k | ||
| Linda D. Cowan United States | 47 | 1.1k 1.1× | 1.4k 2.5× | 617 1.1× | 359 0.8× | 656 1.5× | 101 | 8.2k |
Countries citing papers authored by Robin W.M. Vernooij
Since
Specialization
Citations
This map shows the geographic impact of Robin W.M. Vernooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin W.M. Vernooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin W.M. Vernooij more than expected).
Fields of papers citing papers by Robin W.M. Vernooij
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Robin W.M. Vernooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin W.M. Vernooij. The network helps show where Robin W.M. Vernooij may publish in the future.
Co-authorship network of co-authors of Robin W.M. Vernooij
This figure shows the co-authorship network connecting the top 25 collaborators of Robin W.M. Vernooij. A scholar is included among the top collaborators of Robin W.M. Vernooij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin W.M. Vernooij. Robin W.M. Vernooij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fischer, Felix, P. J. Blankestijn, Robin W.M. Vernooij, et al.. (2025). A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis. Kidney International. 107(4). 728–739.
2.
Visseren, Frank L.J., Marianne C. Verhaar, Daniël H. van Raalte, et al.. (2025). Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies. Diabetologia. 69(1). 36–49.
3.
Pan, Bei, Xiaoman Wang, Honghao Lai, et al.. (2024). Risk of kidney and liver diseases after COVID‐19 infection: A systematic review and meta‐analysis. Reviews in Medical Virology. 34(2). e2523–e2523.
4.
Bała, Małgorzata M, Arnav Agarwal, Kevin C. Klatt, et al.. (2024). Nutrition Users’ Guides: RCTs Part 2 – structured guide for interpreting and applying study results from randomised controlled trials on therapy or prevention questions. BMJ Nutrition Prevention & Health. 7(2). 415–425.
5.
Rookmaaker, Maarten B., et al.. (2024). #2514 Clinical impact of the CKD-EPI 2021 versus the CKD-EPI 2012 formula on GFR estimation and CKD prevalence: results from a Dutch routine-care cohort. Nephrology Dialysis Transplantation. 39(Supplement_1).
6.
Rosa, Giusy Rita Maria La, et al.. (2023). Clinical testing of the cardiovascular effects of e-cigarette substitution for smoking: a living systematic review. Internal and Emergency Medicine. 18(3). 917–928.
7.
Pitre, Tyler, Ellen Cusano, Nadia Khan, et al.. (2023). Methodology and design of platform trials: a meta-epidemiological study. Journal of Clinical Epidemiology. 157. 1–12.
8.
Vernooij, Robin W.M., Arnav Agarwal, Marco H. Blanker, et al.. (2023). Reporting of costs and economic impacts in randomized trials of de-implementation interventions for low-value care: a systematic scoping review. Implementation Science. 18(1). 36–36.
9.
Aaltonen, Riikka, Arnav Agarwal, Marco H. Blanker, et al.. (2023). Timing of symptomatic venous thromboembolism after surgery: meta-analysis. British journal of surgery. 110(5). 553–561.
10.
Vernooij, Robin W.M., et al.. (2023). Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review. Harm Reduction Journal. 20(1). 143–143.
11.
Vernooij, Robin W.M., Arnav Agarwal, Marco H. Blanker, et al.. (2022). Randomized controlled trials in de-implementation research: a systematic scoping review. Implementation Science. 17(1). 65–65.
12.
Guedes, Murilo, Robin W.M. Vernooij, Andrew Davenport, et al.. (2022). Clinical performance, intermediate and long‐term outcomes of high‐volume hemodiafiltration in patients with kidney failure. Seminars in Dialysis. 35(5). 420–426.
13.
Vernooij, Robin W.M., Sanne A. E. Peters, Bernard Canaud, et al.. (2021). The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials. BMC Nephrology. 22(1). 70–70.
14.
Kremer, Daan, Marianne C. Verhaar, Stefan P. Berger, et al.. (2021). A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned. American Journal of Transplantation. 21(12). 3936–3945.
15.
O’Leary, Renée, Giusy Rita Maria La Rosa, Robin W.M. Vernooij, et al.. (2021). Respiratory and Cardiovascular Health Effects of e-Cigarette Substitution: Protocol for Two Living Systematic Reviews. JMIR Research Protocols. 10(5). e29084–e29084.
16.
Krebber, Merle M., Chris Van Dijk, Robin W.M. Vernooij, et al.. (2020). Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 21(18). 6742–6742.
17.
Valli, Claudia, Montserrat Rabassa, Bradley C. Johnston, et al.. (2019). Health-Related Values and Preferences Regarding Meat Consumption. Annals of Internal Medicine.
18.
Vernooij, Robin W.M., et al.. (2019). Quality assessment of clinical practice guidelines for chronic kidney disease: a systematic review. BMC Nephrology. 20(1). 192–192.
19.
Vernooij, Robin W.M., Adegboyega Lawal, Michelle Fiander, et al.. (2018). Effects of oncological care pathways in primary and secondary care on patient, professional, and health systems outcomes: protocol for a systematic review and meta-analysis. Systematic Reviews. 7(1). 246–246.
20.
Flórez, Iván D., Areti‐Angeliki Veroniki, Reem Al Khalifah, et al.. (2018). Comparative effectiveness and safety of interventions for acute diarrhea and gastroenteritis in children: A systematic review and network meta-analysis. PLoS ONE. 13(12). e0207701–e0207701.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Idris Guessous Breakdown of academic impact, for papers by Michail Chourdakis Breakdown of academic impact, for papers by Matthew J. Gurka Breakdown of academic impact, for papers by Hsing‐Yi Chang Breakdown of academic impact, for papers by Stephanie N. Dixon Breakdown of academic impact, for papers by Mark McEvoy Breakdown of academic impact, for papers by Shih‐Han S. Huang Breakdown of academic impact, for papers by Frank J.A. van Rooij Breakdown of academic impact, for papers by Regina El Dib Breakdown of academic impact, for papers by Linda D. Cowan